Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Xu, R; Vujić, N; Bianco, V; Reinisch, I; Kratky, D; Krstic, J; Prokesch, A.
Lipid-associated macrophages between aggravation and alleviation of metabolic diseases.
Trends Endocrinol Metab. 2024;
Doi: 10.1016/j.tem.2024.04.009
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Prokesch Andreas
-
Xu Ruonan
- Co-Autor*innen der Med Uni Graz
-
Bianco Valentina
-
Kratky Dagmar
-
Krstic Jelena
-
Reinisch Isabel Nadine
-
Vujic Nemanja
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Lipid-associated macrophages (LAMs) are phagocytic cells with lipid-handling capacity identified in various metabolic derangements. During disease development, they locate to atherosclerotic plaques, adipose tissue (AT) of individuals with obesity, liver lesions in steatosis and steatohepatitis, and the intestinal lamina propria. LAMs can also emerge in the metabolically demanding microenvironment of certain tumors. In this review, we discuss major questions regarding LAM recruitment, differentiation, and self-renewal, and, ultimately, their acute and chronic functional impact on the development of metabolic diseases. Further studies need to clarify whether and under which circumstances LAMs drive disease progression or resolution and how their phenotype can be modulated to ameliorate metabolic disorders.